Does antigen-specific cytokine response correlate with the experience of oculorespiratory syndrome after influenza vaccine?

Journal of Infectious Diseases

Volumn 187, Issue 3, 2003, Pages 495-499

  Skowronski, Danuta M ^a,g   Lu, Hang ^a,f   Warrington, Richard ^c   Hegele, Richard G ^a   De Serres, Gaston ^h   HayGlass, Kent ^d   Stark, Donald ^a   White, Rick ^a   Macnabb, Jane ^a   Li, Yan ^e   Manson, Heather E ^b   Brunham, Robert C ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Richmond Health Services   (Canada)

^c HEALTH SCIENCES CENTRE   (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

^e PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^f Antex Biologics   (United States)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INFLUENZA VACCINE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 5;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; BLOOD SAMPLING; CANADA; CLINICAL FEATURE; CONTROLLED STUDY; COUGHING; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DRUG INDUCED DISEASE; DYSPNEA; FEMALE; HIGH RISK POPULATION; HUMAN; IMMUNOSTIMULATION; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; OCULORESPIRATORY SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; SORE THROAT; VIRION; WHEEZING;

ADULT; ANTIGENS, VIRAL; CANADA; CYTOKINES; EYE DISEASES; FEMALE; GENE EXPRESSION; HUMANS; HYPERSENSITIVITY, DELAYED; INFLUENZA VACCINES; MALE; MIDDLE AGED; ORTHOMYXOVIRIDAE; RESPIRATORY TRACT DISEASES; RISK FACTORS; SYNDROME; VACCINES, INACTIVATED;

EID: 0037312571     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/368117     Document Type: Article

References (15)

1. National Advisory Committee on Immunization. Supplementary statement on influenza vaccination: continued use of Fluviral influenza vaccine in the 2000-2001 season. Can Commun Dis Rep 2001; 27(ACS-1):1-3.
2. Boulianne N, De Serres G, Duval B, Shadmani R, Rochette L. Clinical manifestations and incidence of oculo-respiratory syndrome following influenza vaccination - Quebec, 2000. Can Commun Dis Rep 2001; 27-10:1-7
3. National Advisory Committee on Immunization. Statement on influenza vaccination for the 2001-2002 season. Can Commun Dis Rep 2001; 27(ACS-4):13-8.
4. National Advisory Committee on Immunization. Supplementary statement for the 2001-2002 season: influenza vaccination of persons who experienced oculo-respiratory syndrome following previous influenza vaccination. Can Commun Dis Rep 2001; 27(ACS-7):1-7.
5. Skowronski DM, Strauss B, De Serres G, et al. Oculo-respiratory syndrome: a new influenza vaccine-associated adverse event? Clin Infect Dis (in press).
6. Blazevic V, Mac Trubey C, Shearer GM. Comparison of in vitro immunostimulatory potential of live and inactivated influenza viruses. Hum Immunol 2000; 61:845-9.
7. Saurwein-Teissl M, Zisterer TL, Schmitt R, Gluck R, Cryz S, Grubeck-Loebenstein B. Whole influenza vaccine activates dendritic cells (DC) and stimulates cytokine production by peripheral blood mononuclear cells (PBMC) while subunit vaccines support T cell proliferation. Clin Exp Immunol 1998; 114:271-6.
8. Alexandrescu V, Manda G, Neagu M, Ciotaru D, Ionita E. The immune response induced by a split influenza vaccine. Studies on cellular immunity. Roum Arch Microbiol Immunol 1997; 56:155-64.
9. Moran TM, Park H, Ferandez-Sesma A, Schulman JL. Th2 responses to inactivated influenza virus can be converted to Th1 responses and facilitate recovery from heterosubtypic virus infection. J Infect Dis 1999; 180:579-85.
10. McElhaney JE, Upshaw CM, Hooton JW, Lechelt KE, Meneilly GS. Responses to influenza vaccination in different T-cell subsets: a comparison of healthy young and older adults. Vaccine 1998; 16:1742-7.
11. McElhaney JE, Meneilly GS, Pinkoski J, Lechelt KE, Bleackley RC. Vaccine-related determinants of the interleukin-2 response to influenza vaccination in healthy young and elderly adults. Vaccine 1995; 13:6-10.
12. Bernstein ED, Gardner EM, Abrutyn E, Gross P, Murasko D. Cytokine production after influenza vaccination in a healthy elderly population. Vaccine 1998; 16:1722-31.
13. Norman GR, Streiner DL. Biostatistics - the bare essentials. 2nd ed. Hamilton: B.C. Decker, 2000:22-3.
14. Skowronski DM, De Serres G, Hebert J, et al. Skin testing to evaluate oculo-respiratory syndrome (ORS) associated with influenza vaccination during the 2000-2001 season. Vaccine 2002; 20:2713-9.
15. Spellberg B, Edwards JE Jr. Type 1/type 2 immunity in infectious diseases. Clin Infect Dis 2001; 32:76-102.